Ontology highlight
ABSTRACT: Introduction
RIP140 (Receptor Interacting Protein) is involved in the regulation of oncogenic signaling pathways and in the development of breast and colon cancers. The aim of the study was to analyze the expression of RIP140 and its partner LCoR in cervical cancers, to decipher their relationship with histone protein modifications and to identify a potential link with patient survival.Methods
Immunohistochemical analyses were carried out to quantify RIP140 and LCoR expression in formalin-fixed paraffin-embedded tissue sections cervical cancer samples. Correlations of RIP140 and LCoR expression with histopathological variables were determined by correlation analyses. Survival rates of patients expressing low or high levels of RIP140 and LCoR were compared by Kaplan-Meier curves.Results
RIP140 overexpression was associated with a significantly shorter overall survival of cervical cancer patients. This effect was significant in the squamous cell carcinoma subtype but not in adenocarcinomas. RIP140 is no longer a significant negative prognosticator for cervical cancer when LCoR expression is low.Discussion
RIP140 is an independent predictor of poor survival of patients with cervical cancer. Patients with tumors expressing low levels of both RIP140 and LCoR showed a better survival compared to patients expressing high levels of RIP140. Modulation of RIP140 and LCoR may represent a novel targeting strategy for cervical cancer prevention and therapy.
SUBMITTER: Vattai A
PROVIDER: S-EPMC5739643 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
Vattai Aurelia A Cavailles Vincent V Sixou Sophie S Beyer Susanne S Kuhn Christina C Peryanova Mina M Heidegger Helene H Hermelink Kerstin K Mayr Doris D Mahner Sven S Dannecker Christian C Jeschke Udo U Kost Bernd B
Oncotarget 20171031 62
<h4>Introduction</h4>RIP140 (Receptor Interacting Protein) is involved in the regulation of oncogenic signaling pathways and in the development of breast and colon cancers. The aim of the study was to analyze the expression of RIP140 and its partner LCoR in cervical cancers, to decipher their relationship with histone protein modifications and to identify a potential link with patient survival.<h4>Methods</h4>Immunohistochemical analyses were carried out to quantify RIP140 and LCoR expression in ...[more]